Rockwell Medical, Inc. (RMTI)Healthcare | Drug Manufacturers - Specialty & Generic | Wixom, United States | NasdaqCM
8.17 USD
+0.42
(5.419%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 8.17 |
Hot Take ↕ | Aug. 22, 2026, 2:35 a.m. EDT
The investment case for Rockwell Medical is currently untenable due to a catastrophic multi-year decline in share price and a complete absence of profitability. While the company recently regained compliance with Nasdaq listing rules and boasts a strong balance sheet relative to its tiny market cap, these positives are overshadowed by a brutal historical trajectory where the stock has lost over 98% of its value since 2016. Fundamentally, the business is failing to generate earnings, with negative profit margins and a sharp contraction in revenue growth for the trailing twelve months. The recent price action shows a slight bounce off lows, but without a turnaround in operations or a credible path to profitability, this appears to be a dead-cat bounce rather than a recovery. The lack of options activity confirms that the market has effectively priced out any near-term hope for a rebound. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.117427 |
| AutoARIMA | 0.148943 |
| AutoETS | 0.148946 |
| MSTL | 0.158153 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.826 |
| Excess Kurtosis | -0.35 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 39.712 |
| Revenue per Share | 17.966 |
| Market Cap | 32,928,900 |
| Forward P/E | 116.71 |
| Beta | 1.62 |
| Profit Margins | -7.33% |
| Website | https://www.rockwellmed.com |
As of Aug. 22, 2026, 2:35 a.m. EDT: Options activity is virtually non-existent, with zero open interest or volume recorded for out-of-the-money contracts and negligible activity in the money. This lack of speculative positioning suggests a complete absence of near-term catalysts or directional bets by traders, reflecting the stock's illiquid and distressed status.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.57650274 |
| Address1 | 30,142 South Wixom road |
| All Time High | 2,079.0 |
| All Time Low | 4.89 |
| Ask | 9.98 |
| Ask Size | 2 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 23,710 |
| Average Daily Volume3 Month | 36,319 |
| Average Volume | 36,319 |
| Average Volume10Days | 23,710 |
| Beta | 1.623 |
| Bid | 5.86 |
| Bid Size | 2 |
| Book Value | 8.833 |
| City | Wixom |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 8.17 |
| Current Ratio | 3.254 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 8.25 |
| Day Low | 7.7 |
| Debt To Equity | 39.712 |
| Display Name | Rockwell Medical |
| Earnings Call Timestamp End | 1,786,622,400 |
| Earnings Call Timestamp Start | 1,786,622,400 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,794,400,200 |
| Earnings Timestamp Start | 1,794,400,200 |
| Ebitda | -2,430,000 |
| Ebitda Margins | -0.03502 |
| Enterprise To Ebitda | -9.08 |
| Enterprise To Revenue | 0.318 |
| Enterprise Value | 22,064,900 |
| Eps Forward | 0.07 |
| Eps Trailing Twelve Months | -1.37 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 248 960 9119 |
| Fifty Day Average | 6.7176 |
| Fifty Day Average Change | 1.4524002 |
| Fifty Day Average Change Percent | 0.2162082 |
| Fifty Two Week Change Percent | -57.650272 |
| Fifty Two Week High | 19.1 |
| Fifty Two Week High Change | -10.93 |
| Fifty Two Week High Change Percent | -0.5722513 |
| Fifty Two Week Low | 4.89 |
| Fifty Two Week Low Change | 3.2800002 |
| Fifty Two Week Low Change Percent | 0.6707567 |
| Fifty Two Week Range | 4.89 - 19.1 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 885,911,400,000 |
| Float Shares | 3,584,937 |
| Forward Eps | 0.07 |
| Forward P E | 116.71429 |
| Free Cashflow | 350,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 157 |
| Fullday Change | 0.42 |
| Fullday Change Percent | 5.41936 |
| Fullday Price | 8.17 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.17712 |
| Gross Profits | 12,290,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14804 |
| Held Percent Institutions | 0.085209996 |
| Implied Shares Outstanding | 4,030,465 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,782,864,000 |
| Last Split Factor | 1:10 |
| Long Business Summary | Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. |
| Long Name | Rockwell Medical, Inc. |
| Market | us_market |
| Market Cap | 32,928,900 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_378060 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -5,239,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 31,719,759 |
| Number Of Analyst Opinions | 2 |
| Open | 7.83 |
| Operating Cashflow | 2,897,000 |
| Operating Margins | -0.05967 |
| Payout Ratio | 0.0 |
| Peg Ratio | 4.43 |
| Phone | 248 960 9009 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 8.17 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 7.75 |
| Price Hint | 2 |
| Price To Book | 0.9249405 |
| Price To Sales Trailing12 Months | 0.47455505 |
| Profit Margins | -0.07327 |
| Quick Ratio | 2.962 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.42 |
| Regular Market Change Percent | 5.41936 |
| Regular Market Day High | 8.25 |
| Regular Market Day Low | 7.7 |
| Regular Market Day Range | 7.7 - 8.25 |
| Regular Market Open | 7.83 |
| Regular Market Previous Close | 7.75 |
| Regular Market Price | 8.17 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 36,436 |
| Return On Assets | -0.051799998 |
| Return On Equity | -0.15525 |
| Revenue Growth | 0.106 |
| Revenue Per Share | 17.966 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,030,465 |
| Shares Percent Shares Out | 0.0218 |
| Shares Short | 88,030 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 85,486 |
| Short Name | Rockwell Medical, Inc. |
| Short Percent Of Float | 0.0224 |
| Short Ratio | 2.76 |
| Source Interval | 15 |
| State | MI |
| Symbol | RMTI |
| Target High Price | 20.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 20.0 |
| Target Median Price | 20.0 |
| Total Cash | 24,797,000 |
| Total Cash Per Share | 6.152 |
| Total Debt | 13,933,000 |
| Total Revenue | 69,389,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.37 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.5154 |
| Two Hundred Day Average Change | -0.34539986 |
| Two Hundred Day Average Change Percent | -0.040561788 |
| Type Disp | Equity |
| Volume | 36,436 |
| Website | https://www.rockwellmed.com |
| Zip | 48,393 |